| Primary |
| Metastases To Bone |
29.3% |
| Breast Cancer |
15.1% |
| Multiple Myeloma |
10.0% |
| Prostate Cancer |
9.4% |
| Osteoporosis |
5.4% |
| Bone Sarcoma |
4.0% |
| Prophylaxis |
3.7% |
| Bone Disorder |
3.5% |
| Breast Cancer Metastatic |
3.2% |
| Plasma Cell Myeloma |
2.9% |
| Hypertension |
2.8% |
| Pneumonia |
1.7% |
| Pain |
1.5% |
| Plasmacytoma |
1.4% |
| Renal Cancer |
1.2% |
| Chemotherapy |
1.1% |
| Osteosarcoma |
1.1% |
| Ewing's Sarcoma |
1.0% |
| Prostate Cancer Metastatic |
1.0% |
| Nausea |
0.8% |
|
| Osteonecrosis Of Jaw |
39.1% |
| Osteonecrosis |
10.4% |
| Tooth Extraction |
9.4% |
| Pain In Jaw |
5.4% |
| Wound Closure |
4.4% |
| Toothache |
4.0% |
| Neoplasm Malignant |
3.0% |
| Pain |
3.0% |
| Vomiting |
2.7% |
| Pyrexia |
2.0% |
| Sequestrectomy |
2.0% |
| Weight Decreased |
2.0% |
| Stem Cell Transplant |
1.7% |
| Surgery |
1.7% |
| Swelling |
1.7% |
| Tooth Loss |
1.7% |
| Vitamin D Decreased |
1.7% |
| Death |
1.3% |
| Neoplasm Progression |
1.3% |
| Pathological Fracture |
1.3% |
|
| Secondary |
| Product Used For Unknown Indication |
15.7% |
| Multiple Myeloma |
15.2% |
| Breast Cancer Metastatic |
9.4% |
| Metastases To Bone |
9.4% |
| Invasive Ductal Breast Carcinoma |
7.4% |
| Metastases To Liver |
7.4% |
| Prostate Cancer |
6.5% |
| Breast Cancer |
6.0% |
| Bone Disorder |
4.9% |
| Prophylaxis |
2.9% |
| Hypertension |
2.7% |
| Osteoporosis |
2.5% |
| Thrombosis |
2.2% |
| Bone Sarcoma |
1.8% |
| Metastatic Renal Cell Carcinoma |
1.3% |
| Plasma Cell Myeloma |
1.1% |
| Cellulitis |
0.9% |
| Colorectal Cancer Metastatic |
0.9% |
| Osteolysis |
0.9% |
| Pain |
0.9% |
|
| Osteonecrosis Of Jaw |
22.3% |
| Osteonecrosis |
11.6% |
| Weight Decreased |
9.8% |
| Pain In Jaw |
6.3% |
| Rash |
5.4% |
| Toxicity To Various Agents |
5.4% |
| Toothache |
4.5% |
| Pain |
3.6% |
| Sequestrectomy |
3.6% |
| Tooth Extraction |
3.6% |
| Tooth Loss |
3.6% |
| Ulcer |
3.6% |
| Vomiting |
3.6% |
| Weight Bearing Difficulty |
2.7% |
| Neoplasm Progression |
1.8% |
| Pyrexia |
1.8% |
| Renal Failure |
1.8% |
| Renal Impairment |
1.8% |
| Swelling |
1.8% |
| Tooth Infection |
1.8% |
|
| Concomitant |
| Prophylaxis |
13.3% |
| Multiple Myeloma |
12.1% |
| Pain |
11.3% |
| Product Used For Unknown Indication |
6.6% |
| Constipation |
5.9% |
| Plasma Cell Myeloma |
5.9% |
| Breast Cancer |
5.1% |
| Nausea |
5.1% |
| Back Pain |
3.9% |
| Breast Cancer Metastatic |
3.9% |
| Hypertension |
3.5% |
| Osteoporosis |
3.5% |
| Metastases To Bone |
3.1% |
| Vomiting |
2.7% |
| Abdominal Pain |
2.3% |
| Colon Cancer |
2.3% |
| Drug Use For Unknown Indication |
2.3% |
| Neuroendocrine Tumour |
2.3% |
| Prophylactic Chemotherapy |
2.3% |
| Type 1 Diabetes Mellitus |
2.3% |
|
| Weight Increased |
10.2% |
| Osteonecrosis Of Jaw |
8.2% |
| Pulmonary Embolism |
8.2% |
| Thrombocytopenia |
8.2% |
| Thrombotic Thrombocytopenic Purpura |
8.2% |
| Pericardial Effusion |
6.1% |
| Skin Haemorrhage |
6.1% |
| Vomiting |
6.1% |
| Lower Respiratory Tract Infection |
4.1% |
| Neutropenic Sepsis |
4.1% |
| Pain In Extremity |
4.1% |
| Plasmacytoma |
4.1% |
| Pulmonary Fibrosis |
4.1% |
| Transient Ischaemic Attack |
4.1% |
| Urinary Tract Infection |
4.1% |
| Anaemia |
2.0% |
| B-cell Lymphoma Stage I |
2.0% |
| Blood Product Transfusion Dependent |
2.0% |
| Bone Disorder |
2.0% |
| Bronchopneumonia |
2.0% |
|
